A phase I study of the safety and possible toxicity of a novel ayurvedic preparation - Sudarshana Suspension

dc.contributor.author	Weerakoon, W.A.S.S.
dc.contributor.author	Perera, P.K.
dc.contributor.author	Gunasekera, D.
dc.contributor.author	Suresh, T.S.
dc.date.accessioned	2017-11-06T02:31:13Z
dc.date.available	2017-11-06T02:31:13Z
dc.date.issued	2016
dc.identifier.citation	Weerakoon, W.A.S.S., Perera, P.K., Gunasekera, D., Suresh, T.S. (2016). "A phase I study of the safety and possible toxicity of a novel ayurvedic preparation - Sudarshana Suspension", Proceedings of Second International Conference on Natural Products Genomics and Drug Discovery - 2016, p. 17	en_US, si_LK
dc.identifier.uri	http://dr.lib.sjp.ac.lk/handle/123456789/6468
dc.description.abstract	Attached	en_US, si_LK
dc.description.abstract	Introduction: Sudarshana powder (SP) is a very effective anti-pyretic Ayurveda preparation. The extreme bitterness of this powder reduces the patient compliance and administration to children is very difficult. Therefore this powder was developed into a user-friendly standard Ayurveda suspension. Objective: The aim of this present study was to evaluate the safety/possible toxicity of the novel formulation, Sudarshana suspension (SS) in a group of healthy adult volunteers. Methodology: The study protocol was approved by the institutional ethics review committees and registered in Sri Lanka Clinical Trials Registry. Study was carried out in Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura. Healthy adult volunteers (n=35) of
dc.language.iso	en_US	en_US, si_LK
dc.publisher	Proceedings of Second International Conference on Natural Products Genomics and Drug Discovery - 2016	en_US, si_LK
dc.title	A phase I study of the safety and possible toxicity of a novel ayurvedic preparation - Sudarshana Suspension	en_US, si_LK
dc.type	Article	en_US, si_LK